140 related articles for article (PubMed ID: 36890182)
1. Prognostic significance of pre- and post-treatment hematological biomarkers in patients with head and neck cancer treated with chemoradiotherapy.
Iwasa YI; Shimizu M; Matsuura K; Hori K; Hiramatsu K; Sugiyama K; Yokota Y; Kitano T; Kitoh R; Takumi Y
Sci Rep; 2023 Mar; 13(1):3869. PubMed ID: 36890182
[TBL] [Abstract][Full Text] [Related]
2. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment Neutrophil/Lymphocyte Ratio Is a Prognostic Factor in Head and Neck Cancers Treated With Nivolumab.
Iwasa YI; Kitoh R; Yokota Y; Hori K; Kasuga M; Kobayashi T; Kanda S; Takumi Y
Cancer Diagn Progn; 2024; 4(2):182-188. PubMed ID: 38434918
[TBL] [Abstract][Full Text] [Related]
4. Objective evaluation of nutritional status using the prognostic nutritional index during and after chemoradiotherapy in Japanese patients with head and neck cancer: a retrospective study.
Fujiwara D; Tsubaki M; Takeda T; Miura M; Nishida S; Sakaguchi K
Eur J Hosp Pharm; 2021 Sep; 28(5):266-270. PubMed ID: 34426479
[TBL] [Abstract][Full Text] [Related]
5. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
6. Clinical Application Value of the Prognostic Nutritional Index for Predicting Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy or Radiotherapy.
Xiao L; Lyu J; Liu X; Li K; Wang Y; Zhang R; Chen T; Li T
Nutr Cancer; 2021; 73(10):1933-1940. PubMed ID: 33044092
[TBL] [Abstract][Full Text] [Related]
7. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
Front Nutr; 2022; 9():896847. PubMed ID: 35990358
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients.
Xiong Y; Shi LL; Zhu LS; Peng G
Ann Palliat Med; 2021 Apr; 10(4):4122-4133. PubMed ID: 33832314
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis.
Luan CW; Tsai YT; Yang HY; Chen KY; Chen PH; Chou HH
Sci Rep; 2021 Aug; 11(1):17117. PubMed ID: 34429476
[TBL] [Abstract][Full Text] [Related]
10. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
Zhang Y; Kong FF; Zhu ZQ; Shan HX
BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
12. Assessment of Peripheral Platelet to Lymphocyte Ratio and Prognostic Nutritional Index in the Efficacy and Prognosis of Radiotherapy for Cervical Cancer.
Gao Z; Zhao M; Yang X; Fu J
Curr Oncol; 2023 Feb; 30(3):2834-2844. PubMed ID: 36975429
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic evaluation of nutritional indicators in patients with limited-stage small cell lung cancer].
Zhang JQ; Wang YY; Xu KP; Qi J; Wang X; Xu LM; Liu NN; Zhao LJ; Wang P
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):937-942. PubMed ID: 31874552
[No Abstract] [Full Text] [Related]
14. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.
Araki T; Tateishi K; Komatsu M; Sonehara K; Wasamoto S; Koyama S; Yoshiike F; Hama M; Nishie K; Kondo D; Agatsuma T; Kato A; Takata M; Kanda S; Hanaoka M; Koizumi T
Thorac Cancer; 2022 Jul; 13(14):2031-2040. PubMed ID: 35616056
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of prognostic nutritional index and its variations in advanced non-small-cell lung cancer patients treated with anlotinib monotherapy.
Chen T; Liang G; Xiang Z; He J; Xu X; Tang M
J Clin Lab Anal; 2022 Apr; 36(4):e24300. PubMed ID: 35179795
[TBL] [Abstract][Full Text] [Related]
18. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
[TBL] [Abstract][Full Text] [Related]
19. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
Chandrasekara S; Davis S; Thomson P; Haydon A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
[TBL] [Abstract][Full Text] [Related]
20. Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy.
Ozdemir Y; Topkan E; Mertsoylu H; Selek U
Cancer Manag Res; 2020; 12():1959-1967. PubMed ID: 32214853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
